Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer

NCT00045032 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5099

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Herceptin
DRUG: Herceptin

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]